"Repurposing fusion inhibitor peptide against SARS-CoV-2."

Faiyaz Md. Efaz et al. (2021)

Details and statistics

DOI: 10.1002/JCC.26758

access: closed

type: Journal Article

metadata version: 2023-09-30

a service of  Schloss Dagstuhl - Leibniz Center for Informatics